Annual mammograms are important and AdventHealth now offers enhanced screening for women with dense breast tissue as well as ...

Asset Management One Co. Ltd. cut its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 0.5% in the 3rd quarter, ...

Hologic (HOLX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tejas Savant ...

Analyst Michael Matson from Needham reiterated a Buy rating on Hologic (HOLX – Research Report) and keeping the price target at $90.00.

Q4 2024 Earnings Call Transcript November 4, 2024 Hologic, Inc. reports earnings inline with expectations. Reported EPS is $1 ...

The firm reported a 13 percent jump in its non-COVID molecular diagnostics revenues year over year while its breast health and GYN Surgical business revenues rose 6 percent.

While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics ...

Good afternoon, and welcome to the Hologic's Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Shelly, and I am your operator for today’s call. Today's conference is being recorded. All ...

Company Expects Strong Execution of its Broad-Based Growth Strategy in Fiscal 2025 – MARLBOROUGH, Mass., November 04, ...